Skip to main content

New Drug Screening Model Using Enzymes Immobilized on Mesoporous Materials: A Proof-of-Concept Study Using Immobilized α-Glucosidase and Acarbose

Buy Article:

$107.14 + tax (Refund Policy)

Enzyme immobilization increases the availability of the enzyme to the substrate with a higher turnover over a considerable period. For this purpose, a variety of mesoporous materials with different diameters were synthesized by various methods using different ratios of P123 (template agent) to 1,3,5-trimethylbenzene (expanding agent). These versatile materials were then characterized by transmission electron microscopy and N2 adsorption–desorption analysis. α-Glucosidase was successfully immobilized on all the synthesized materials, but the P123/TMB = 4/3-COOH-PMO material had a higher loading rate and enzyme activity. Furthermore, applications of this material were best performed in a column to immobilize the enzymes. Additionally, the synthesized material was further tested using acarbose as a model compound for drug screening. The immobilized α-glucosidase was packed into a column and connected to HPLC instrument to screen 20 small molecular compounds. Using this method, several drugs that might strongly inhibit α-glucosidase were identified. Therefore, this method can be further used in drug screening for chemical drugs and traditional Chinese medicines to expedite new drug research.

Keywords: Drug Screening; Immobilized α-Glucosidase; Mesoporous Materials

Document Type: Research Article

Affiliations: School of Life Science, Beijing Institute of Technology, Beijing 100081, China

Publication date: 01 December 2016

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content